Rare diseases
Investigational molecules
Locations
Long-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GermanyLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
GermanyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
GermanyA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
GermanyStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
GermanyA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
GermanyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
GermanyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
GermanyA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
